| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 837 | 2024 |
| Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies Y Xuan, NW Bateman, S Gallien, S Goetze, Y Zhou, P Navarro, M Hu, ... Nature communications 11 (1), 5248, 2020 | 64 | 2020 |
| CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment M Seyfrid, WT Maich, MV Shaikh, N Tatari, D Upreti, D Piyasena, ... Journal for immunotherapy of cancer 10 (1), 2022 | 47 | 2022 |
| Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry A Khoo, LY Liu, JO Nyalwidhe, OJ Semmes, D Vesprini, MR Downes, ... Nature Reviews Urology 18 (12), 707-724, 2021 | 45 | 2021 |
| Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia JC Kim, M Chan-Seng-Yue, S Ge, AGX Zeng, K Ng, OI Gan, L Garcia-Prat, ... Nature genetics 55 (7), 1186-1197, 2023 | 28 | 2023 |
| Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena A Khoo, LY Liu, TY Sadun, A Salmasi, A Pooli, E Felker, KE Houlahan, ... Journal of hematology & oncology 15 (1), 48, 2022 | 14 | 2022 |
| Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma MA Qazi, SK Salim, KR Brown, N Mikolajewicz, N Savage, H Han, ... Cell Reports 40 (13), 111420, 2022 | 8 | 2022 |
| Prostate cancer reshapes the secreted and extracellular vesicle urinary proteomes A Khoo, M Govindarajan, Z Qiu, LY Liu, V Ignatchenko, M Waas, ... Nature Communications 15 (1), 5069, 2024 | 5 | 2024 |
| Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium M Waas, A Khoo, P Tharmapalan, CW McCloskey, M Govindarajan, ... Cell Reports Methods 4 (4), 2024 | 1 | 2024 |
| Comprehensive Prostate Fluid-Based Spectral Libraries for Enhanced Protein Detection in Urine A Ha, A Khoo, V Ignatchenko, S Khan, M Waas, D Vesprini, SK Liu, ... Journal of Proteome Research 23 (5), 1768-1778, 2024 | 1 | 2024 |
| Standardization and harmonization of distributed multi-national proteotype analysis supporting precision medicine studies Y Xuan, NW Bateman, S Gallien, S Goetze, Y Zhou, P Navarro, M Hu, ... bioRxiv, 2020.03. 12.988089, 2020 | 1 | 2020 |
| Optimizing the large-scale production of Saw1 and the Saw1-Rad1-Rad10 nuclease complex for structural studies M Rashev | 1 | 2017 |
| Protocol for generating high-fidelity proteomic profiles using DROPPS M Waas, M Govindarajan, A Khoo, C Zuo, A Aastha, J He, M Woolman, ... STAR protocols 5 (4), 103397, 2024 | | 2024 |
| Whole slide Imaging Mass Cytometry allows the rapid profiling of the immune landscape of histopathologically aggressive prostate tumors JL Gorman, LY Liu, JP Hartig, N Parsotam, A Khoo, V Ignatchenko, ... Cancer Research 84 (6_Supplement), 5561-5561, 2024 | | 2024 |
| Pan-cancer N-glycoproteomic atlas of patient derived xenografts uncovers FAT2 as a therapeutic target for head and neck cancers M Govindarajan, S Mejia-Guerrero, SC Chafe, S Khan, W Shi, M Waas, ... bioRxiv, 2024.12. 11.627962, 2024 | | 2024 |
| Biomarkers for identifying mpmri visable tumours and assessing tumour aggressiveness of prostate cancer T Kislinger, PC Boutros, A Khoo, Y Liu US Patent App. 18/116,963, 2023 | | 2023 |
| Droplet based low input proteomic platform for rare cell populations M Waas, A Khoo, P Tharmapalan, CW McCloskey, M Govindarajan, ... bioRxiv, 2023.09. 11.557098, 2023 | | 2023 |
| Characterization of the Minimal Residual Disease in Human Glioblastoma MA Qazi, S Salim, N Savage, K Brown, N Mikolajewicz, H Han, A Khoo, ... JOURNAL OF NEUROSURGERY 135 (2), 14-14, 2021 | | 2021 |
| Hitting more birds with one stone: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma M Seyfrid, W Maich, MV Shaikh, N Tatari, D Upreti, D Piyasena, ... bioRxiv, 2021.06. 02.446670, 2021 | | 2021 |
| Abstract PS18-31: Identification of cell surface proteins in triple negative breast cancer for the development of novel targeted therapies L Kuhlmann, A Sinha, V Ignatchenko, A Macklin, L Liu, M Govindarajan, ... Cancer Research 81 (4_Supplement), PS18-31-PS18-31, 2021 | | 2021 |
